View Older Stories
-
Endo International (ENDP) Files for Chapter 11 Bankruptcy Relief
-
Endo files for bankruptcy as U.S. opioid litigation drags
-
Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Strengthen Financial Position and Advance Ongoing Business Transformation
-
Endo (ENDP) Unsecured Noteholders Group Reiterates That Bankruptcy Is Unwarranted in Light of Recent Results - DJ
-
Endo International (ENDP) expects negotiations will likely result in a pre-arranged filing under Chapter 11
-
ENDO REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS
-
Endo International (ENDP) Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in Canada
-
Endo Announces Agreement for Paladin Labs to Develop, Commercialize and Supply Quoin Pharmaceuticals' QRX003 in Canada
-
Endo (ENDP) is moving toward a bankruptcy filing - WSJ
-
Endo International (ENDP) Announces Opana ER Antitrust Jury Verdict in Company's Favor
-
Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor
-
Endo International (ENDP) Reports Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum
-
Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolyticum (CCH) in Participants with Adhesive Capsulitis of the Shoulder
-
Endo International (ENDP) Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain
-
Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain
-
ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS
-
Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting
-
Endo (ENDP) Acquires Six Development-Stage Product Candidates From Nevakar
-
Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar
-
Endo International (ENDP) Announces Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability
-
Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo
-
Endo International (ENDP) Launches Direct-to-Consumer Campaign for Qwo
-
Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events
-
ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS
-
Endo International (ENDP) Comment on Default Judgment on Liability in Tennessee State Court
-
Endo Comments on Default Judgment on Liability in Tennessee State Court
-
Endo International (ENDP) Launches Ready-to-Use VASOSTRICT
-
Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-Mix Bottles
-
Endo International (ENDP) Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims
-
Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims
-
Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Development
-
Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients: Watching Education Unfold
-
Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution
-
Endo International (ENDP) to Settle Texas Governmental Opioid Cases and Claims
-
Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims
-
Endo International (ENDP) Enters Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI in Canada
-
Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPRI® (Cenobamate) in Canada
-
Endo International (ENDP) Announces Favorable Final California Opioid Ruling
-
Endo Announces Favorable Final Ruling in California State Court Opioid Trial
-
Endo International (ENDP) Commences Shipments of Generic MIACALCIN
-
Endo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) Injection
-
Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance
-
Teva (TEVA), Endo (ENDP) Weakness Tied to Mallinckrodt (MNK) Bankruptcy Report
-
Endo (ENDP), J&J (NYSE: JNJ), Others Look to Participate in Purdue Pharma's Bankruptcy to Settle Opioid Litigation - WSJ
-
Pre-Open Movers 05/13: (AMBR) (CPRX) (CLRB) Higher; (WFT) (INSY) (UBER) (more...)
-
Endo International plc (ENDP) and Mallinckrodt (MNK) Would Be Beneficiaries Of Purdue Bankruptcy - Mizuho
-
Wall St. closes at 2016 high as Fed signals fewer rate hikes
-
Hercules Technology (HTGC) Issues Update on Q4 Portfolio Activity
-
Notable 52-Week High's and Low's of the Day 08/18: POT, ENDP, NANO High; APP, IIN, RRC Low
-
Morning Movers 6/8: CASC, ABK, PPCO, DRRX, DCTH, DEPO Higher; NWY, CHP, DOVR, PBY Lower
